What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma.

CME information and select publications here